Gorantla Santhi, Sneller Hannah, Walters Lisa, Sharp John G, Pirruccello Samuel J, West John T, Wood Charles, Dewhurst Stephen, Gendelman Howard E, Poluektova Larisa
Centere for Neurovirology and Neurodegenerative Disorders, Department of Pharmacology, University of Nebraska Medical Center, 985880 Nebraska Medical Center, Omaha, NE 68198-5880, USA.
J Virol. 2007 Mar;81(6):2700-12. doi: 10.1128/JVI.02010-06. Epub 2006 Dec 20.
The specificity of human immunodeficiency virus type 1 (HIV-1) for human cells precludes virus infection in most mammalian species and limits the utility of small animal models for studies of disease pathogenesis, therapy, and vaccine development. One way to overcome this limitation is by human cell xenotransplantation in immune-deficient mice. However, this has proved inadequate, as engraftment of human immune cells is limited (both functionally and quantitatively) following transplantation of mature human lymphocytes or fetal thymus/liver. To this end, a human immune system was generated from umbilical cord blood-derived CD34(+) hematopoietic stem cells in BALB/c-Rag2(-/-)gamma(c)(-/-) mice. Intrapartum busulfan administration followed by irradiation of newborn pups resulted in uniform engraftment characterized by human T-cell development in thymus, B-cell maturation in bone marrow, lymph node development, immunoglobulin M (IgM)/IgG production, and humoral immune responses following ActHIB vaccination. Infection of reconstituted mice by CCR5-coreceptor utilizing HIV-1(ADA) and subtype C 1157 viral strains elicited productive viral replication and lymphadenopathy in a dose-dependent fashion. We conclude that humanized BALB/c-Rag2(-/-)gamma(c)(-/-) mice represent a unique and valuable resource for HIV-1 pathobiology studies.
1型人类免疫缺陷病毒(HIV-1)对人类细胞的特异性使得该病毒无法感染大多数哺乳动物物种,限制了小动物模型在疾病发病机制、治疗和疫苗开发研究中的应用。克服这一限制的一种方法是将人类细胞异种移植到免疫缺陷小鼠体内。然而,事实证明这种方法并不充分,因为在移植成熟的人类淋巴细胞或胎儿胸腺/肝脏后,人类免疫细胞的植入受到限制(在功能和数量上)。为此,利用来自脐带血的CD34(+)造血干细胞在BALB/c-Rag2(-/-)γ(c)(-/-)小鼠体内构建了人类免疫系统。在分娩时给予白消安,随后对新生幼崽进行照射,结果实现了均匀植入,其特征包括胸腺中人类T细胞的发育、骨髓中B细胞的成熟、淋巴结的发育、免疫球蛋白M(IgM)/IgG的产生以及接种ActHIB疫苗后的体液免疫反应。利用HIV-1(ADA)和C亚型1157病毒株通过CCR5共受体感染重建后的小鼠,引发了有活性的病毒复制和淋巴结病,且呈剂量依赖性。我们得出结论,人源化BALB/c-Rag2(-/-)γ(c)(-/-)小鼠是HIV-1病理生物学研究的一种独特且有价值的资源。